Kamada (KMDA) Long-Term Investments (2012 - 2022)

Kamada (KMDA) posted quarterly Long-Term Investments of $102.0 million for Q4 2022, down 1.88% year-on-year from $103.9 million in Q4 2021, and down 1.88% on a QoQ basis from $103.9 million in Q4 2021.

Kamada (KMDA) Long-Term Investments (2012 - 2022) Analysis & Trends

Kamada (KMDA) has reported Long-Term Investments for 10 consecutive years, with $102.0 million the latest figure, recorded in Q4 2022.

  • Quarterly Long-Term Investments fell 1.88% year-over-year to $102.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $102.0 million (down 1.88% YoY) and the FY2022 annual result came in at $102.0 million, down 1.88% from the prior year.
  • Long-Term Investments declined to $102.0 million in Q4 2022 per KMDA's latest filing, from $103.9 million in the prior quarter.
  • Over the last five years, Long-Term Investments for KMDA reached as high as $156.5 million in Q2 2019 and fell as low as $8.6 million in Q4 2019.
  • A 4-year average of $98.2 million and a median of $115.1 million in 2018 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2018 — Long-Term Investments rose 29.43% — and 2019, when it fell 2.04%.
  • Year by year, Long-Term Investments stood at $8.7 million in 2018, then declined by 2.04% to $8.6 million in 2019, then soared by 1114.19% to $103.9 million in 2021, then decreased by 1.88% to $102.0 million in 2022.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $102.0 million, $103.9 million, and $8.6 million for Q4 2022, Q4 2021, and Q4 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 56.09 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.32 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 702.35 Mn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 146.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 101.96 Mn
Dec 31, 2021 103.91 Mn
Dec 31, 2019 8.56 Mn
Jun 30, 2019 156.49 Mn
Mar 31, 2019 145.10 Mn
Dec 31, 2018 8.74 Mn
Sep 30, 2018 115.12 Mn
Jun 30, 2018 123.69 Mn
Mar 31, 2018 120.53 Mn
Dec 31, 2017 8.60 Mn
Sep 30, 2017 111.99 Mn
Jun 30, 2017 100.20 Mn
Mar 31, 2017 93.13 Mn
Dec 31, 2016 9.16 Mn
Sep 30, 2016 94.60 Mn
Jun 30, 2016 98.57 Mn
Mar 31, 2016 106.64 Mn
Dec 31, 2015 101.99 Mn
Sep 30, 2015 108.43 Mn
Jun 30, 2015 1.46 Mn